Cart
sales@molnova.com
ICI 174,864
CAS No. 89352-67-0
ICI 174,864( —— )
Catalog No. M30662 CAS No. 89352-67-0
Selective δ opioid antagonist. Exhibits partial agonist in vitro activity at δ receptors at high concentrations.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 387 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameICI 174,864
-
NoteResearch use only, not for human use.
-
Brief DescriptionSelective δ opioid antagonist. Exhibits partial agonist in vitro activity at δ receptors at high concentrations.
-
DescriptionSelective δ opioid antagonist. Exhibits partial agonist in vitro activity at δ receptors at high concentrations.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number89352-67-0
-
Formula Weight691.87
-
Molecular FormulaC38H53N5O7
-
Purity>98% (HPLC)
-
SolubilityDMSO:69.19 mg/mL;water:1 mg/ml
-
SMILESCC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)[C@H](CC1=CC=C(O)C=C1)N(CC=C)CC=C)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cohen et al (1996) Opioid agonist activity of ICI 174864 and its carboxypeptidase degradation product, LY281217. J.Pharmacol.Exp.Ther. 238 769 PMID:
molnova catalog
related products
-
Nociceptin (1-13) am...
Nociceptin (1-13), amide is a potent agonist Opioid receptor-like1 (ORL1) receptor with a pEC50 of 7.9 for mouse vas deferens and a Ki of 0.75 nM for binding to rat forebrain membranes.
-
LY 2456302
LY 2456302 (CERC-501, JSPA 0658, Aticaprant) is a potent, selective, short-acting antagonist of κ-opioid receptor (KOR) with Ki of 0.81 nM.
-
Cebranopadol
Cebranopadol (GRT-6005, GRT6005) is a potent analgesic nociceptin/orphanin FQ peptide (NOP) and opioid receptor agonist with Ki/EC50 of 0.9/13 nM (human NOP receptor), 0.7/1.2 nM (mu-opioid receptor).
